SEC Drops Insider Trading Case Over J&J Deal
Following a mistrial, the U.S. Securities and Exchange Commission has dropped a suit against the head of a medical device company accused of trading on inside knowledge of Johnson & Johnson's...To view the full article, register now.
Already a subscriber? Click here to view full article